reninangiotensin
system
ra
play
import
role
regul
blood
pressur
bodi
fluid
homeostasi
tradit
ra
view
circul
system
circul
ra
howev
wellestablish
angiotensin
ang
gener
also
occur
tissu
site
tissu
ra
complex
system
increas
even
know
ang
ii
activ
one
receptor
ang
ii
metabolit
activ
receptor
may
even
receptor
renin
prorenin
review
summar
latest
insight
tissu
angiotensin
gener
focus
particular
activ
ang
ii
type
receptor
local
gener
ang
ii
renin
belong
famili
aspartyl
proteas
one
known
substrat
angiotensinogen
precursor
angiotensin
peptid
structur
analysi
reveal
renin
consist
homolog
lobe
form
cleft
contain
activ
site
renin
inact
precursor
prorenin
activ
site
cover
proseg
renin
gene
clone
human
rat
mous
speci
one
renin
gene
c
although
mous
strain
two
renin
gene
submandibular
variant
design
gene
encod
nonglycosyl
prorenin
oppos
gene
glycosyl
three
asparagin
residu
renin
gene
locat
chromosom
human
mous
wherea
local
chromosom
rat
renin
gene
encod
preprorenin
consist
preseg
amino
acid
proseg
amino
acid
actual
renin
protein
amino
acid
morri
preseg
function
signal
peptid
direct
prorenin
secretori
pathway
recent
splicevari
renin
gene
discov
lack
signal
peptid
part
proseg
truncat
prorenin
display
enzymat
activ
truncat
proseg
partial
cover
enzymat
cleft
thought
remain
intracellular
clausmey
et
al
although
truncat
prorenin
also
demonstr
extracellularli
shinagawa
et
al
mice
lack
gene
character
sexual
dimorph
hypotens
lead
signific
reduct
blood
pressur
femal
mice
absenc
dens
secretorystorag
granul
format
juxtaglomerular
cell
alter
morpholog
kidney
signific
increas
plasma
prorenin
level
clark
et
al
delet
gene
result
increas
renin
decreas
prorenin
level
sharp
et
al
chang
blood
pressur
morpholog
chang
occur
transgen
mice
overexpress
human
renin
develop
hypertens
wherea
transgen
mice
express
human
renin
human
angiotensinogen
show
significantli
increas
blood
pressur
fukamizu
et
al
plasma
concentr
ang
ang
ii
increas
doubl
transgen
mice
compar
either
control
mice
transgen
mice
overexpress
human
renin
result
demonstr
human
renin
crossreact
mous
angiotensinogen
therebi
illustr
uniqu
speci
specif
ra
prorenin
activ
cleavag
proseg
proteolyt
activ
via
conform
chang
induc
low
ph
low
temperatur
nonproteolyt
activ
danser
deinum
fig
proteolyt
activ
irrevers
process
proseg
cleav
eg
kallikrein
trypsin
plasmin
vivo
proteolyt
activ
probabl
mediat
proconvertas
reninproduc
cell
juxtaglomerular
apparatu
kidney
nonproteolyt
activ
prorenin
revers
process
prorenin
convert
close
inact
open
activ
conform
unfold
proseg
enzymat
cleft
acid
activ
lead
complet
activ
prorenin
wherea
exposur
cold
cryoactiv
lead
partial
activ
kinet
studi
shown
equilibrium
exist
close
open
conform
prorenin
physiolog
condit
ph
c
prorenin
open
conform
danser
deinum
kidney
main
sourc
circul
pro
renin
howev
follow
bilater
nephrectomi
prorenin
contrast
renin
remain
detect
suggest
prorenin
also
produc
outsid
kidney
potenti
extraren
proreninproduc
tissu
eye
adren
ovari
testi
sealey
et
al
danser
et
al
itskovitz
et
al
clausmey
et
al
normal
concentr
prorenin
human
plasma
time
higher
renin
reason
excess
unknown
prorenin
seem
activ
lenz
et
al
one
possibl
prorenin
function
unrel
angiotensin
gener
regard
interest
note
recent
suggest
prorenin
bind
pro
renin
receptor
therebi
activ
second
messeng
pathway
manner
independ
ang
ii
nguyen
et
al
sari
et
al
pro
renin
receptor
may
also
mediat
uptak
renin
andor
prorenin
tissu
synthes
renin
prorenin
like
heart
vessel
wall
date
two
pro
reninbind
receptor
identifi
receptor
sari
et
al
abovement
pro
renin
receptor
receptor
ident
insulinlik
growth
factor
ii
igfii
receptor
bind
igfii
protein
prorenin
renin
retino
acid
distinct
site
kornfeld
kang
et
al
prorenin
renin
rapidli
intern
bind
receptor
intern
prorenin
proteolyt
convert
renin
howev
bind
receptor
result
angiotensin
gener
either
intraor
extracellularli
combin
fact
intracellularli
gener
renin
found
degrad
within
hour
suggest
receptor
function
clearanc
receptor
pro
renin
altern
sinc
bind
protein
receptor
result
activ
second
messeng
pathway
involv
gprotein
di
bacco
gill
pro
renin
may
act
receptor
agonist
pro
renin
receptor
clone
nguyen
cowork
nguyen
et
al
prorenin
renin
bind
equal
well
receptor
without
intern
degrad
interestingli
catalyt
activ
bound
renin
increas
receptorbound
prorenin
becam
fulli
activ
nonproteolyt
manner
thu
appar
receptor
allow
prorenin
gener
angiotensin
tissu
site
importantli
bind
pro
renin
pro
renin
receptor
human
mesangi
cell
also
induc
ang
iiindepend
effect
increas
dna
synthesi
activ
mitogenactiv
protein
kinas
mapk
extracellular
signalregul
kinas
erk
plasminogenactiv
releas
furthermor
cardiomyocyt
prorenin
activ
mapkheat
shock
protein
pathway
result
chang
actin
filament
dynam
sari
et
al
nonangiotensinmedi
effect
may
underli
blood
pressureindepend
cardiac
hypertrophi
rat
hepat
prorenin
overexpress
et
al
final
peter
cowork
demonstr
prorenin
intern
cardiomyocyt
transgen
rat
express
mous
gene
liver
peter
et
al
sinc
prorenin
nonglycosyl
phenomenon
mediat
receptor
intern
contrast
observ
recent
clone
pro
renin
receptor
thu
may
third
pro
renin
receptor
ident
current
unclear
angiotensinogen
precursor
angiotensin
metabolit
known
substrat
renin
angiotensinogen
gene
encod
glycoprotein
amino
acid
molecular
weight
kda
gene
locat
singl
copi
respect
chromosom
rat
chromosom
mice
chromosom
human
doolittl
report
signific
sequenc
homolog
angiotensinogen
antitrypsin
ovalbumin
antithrombin
iii
doolittl
protein
member
serin
proteinas
inhibitor
famili
close
associ
acut
inflamm
reaction
acut
inflamm
induc
gene
express
via
acuterespons
increas
angiotensinogen
concentr
plasma
kageyama
et
al
similar
structur
organ
angiotensinogen
gene
suggest
gene
evolv
common
ancestor
kitamura
et
al
although
angiotensinogen
mrna
detect
brain
adipocyt
heart
reproduct
system
main
sourc
liver
paul
et
al
hepatocyt
constitut
secret
angiotensinogen
extracellular
fluid
without
intracellular
storag
blood
plasmaextracellular
fluid
function
major
reservoir
angiotensinogen
angiotensinogen
plasma
concentr
approxim
michaelismenten
constant
renin
reaction
make
ra
activ
sensit
small
chang
angiotensinogen
concentr
delet
angiotensinogen
gene
mice
lead
hypotens
low
bodi
weight
gain
birth
abnorm
morpholog
kidney
heart
turn
overexpress
angiotensinogen
led
develop
hypertens
kimura
et
al
two
isoform
ace
exist
somat
ace
testi
germin
ace
somat
ace
abundantli
express
throughout
bodi
wherea
testi
ace
exclus
express
testi
clone
ace
gene
provid
better
understand
relationship
somat
testi
ace
form
transcrib
gene
use
differ
promot
hubert
et
al
human
ace
gene
locat
chromosom
somat
ace
homolog
domain
share
sequenc
homolog
domain
contain
catalyt
activ
site
wei
et
al
situat
nand
ctermin
side
ace
accord
posit
design
nand
cdomain
major
somat
ace
membranebound
endotheli
cell
circul
ace
deriv
aceexpress
cell
proteolyt
cleavag
juxtamembran
stalk
region
wei
et
al
testi
ace
possess
one
catalyt
domain
ident
cdomain
somat
ace
studi
select
block
cand
ndomain
somat
ace
reveal
convers
ang
ang
ii
membranebound
ace
depend
cdomain
wherea
domain
contribut
convers
solubl
ace
van
esch
et
al
degrad
bradykinin
tissu
site
also
requir
domain
tom
et
al
delet
somat
testi
ace
ace
mice
led
hypotens
male
infertil
chang
kidney
morpholog
esther
et
al
vascular
express
germin
ace
ace
null
mice
restor
renal
morpholog
normal
blood
pressur
thu
demonstr
germin
ace
function
substitut
somat
ace
kessler
et
al
recent
homologu
somat
ace
call
discov
donoghu
et
al
share
homolog
cand
ntermin
domain
somat
ace
gene
encod
locat
x
chromosom
mainli
express
endotheli
cell
heart
kidney
testi
like
somat
ace
releas
circul
proteolyt
cleavag
turner
hooper
unlik
somat
ace
one
catalyt
activ
site
convert
ang
ang
ii
ang
ang
respect
donoghu
et
al
vicker
et
al
data
suggest
potenti
role
counterregul
high
blood
pressur
inactiv
ang
ii
inde
model
ang
iidepend
hypertens
blood
pressur
substanti
higher
mice
wildtyp
control
gurley
et
al
mice
lack
gene
origin
describ
develop
abnorm
heart
function
sever
impair
contractil
crackow
et
al
confirm
followup
studi
gurley
et
al
remark
also
function
receptor
viru
caus
sever
acut
respiratori
syndrom
therebi
stress
import
manner
unrel
ra
li
et
al
initi
thought
respons
ang
ii
mediat
singl
ang
ii
receptor
end
discoveri
specif
ang
ii
receptor
ligand
losartan
made
possibl
identifi
sever
ang
ii
receptor
subtyp
know
biolog
action
ang
ii
man
mediat
least
two
type
ang
ii
receptor
ang
ii
type
receptor
fig
receptor
mediat
virtual
known
physiolog
action
ang
ii
vasoconstrict
inotropi
chronotropi
aldosteron
releas
noradrenalin
releas
growth
stimul
receptor
gene
encod
protein
amino
acid
molecular
weight
kda
gene
first
clone
rat
vascular
smooth
muscl
cell
murphi
et
al
bovin
adren
gland
sasaki
et
al
clone
genet
analysi
human
receptor
gene
reveal
human
receptor
gene
locat
chromosom
produc
two
isoform
altern
splice
isoform
similar
bind
function
properti
rodent
two
subtyp
receptor
identifi
elton
et
al
origin
subtyp
lie
gene
duplic
occur
diverg
rodent
humanartiodactyl
group
million
year
ago
share
sequenc
homolog
locat
chromosom
rat
chromosom
mice
respect
surprisingli
subtyp
similar
ligand
bind
affin
signal
transduct
properti
vari
express
level
differ
tissu
receptor
predomin
heart
kidney
lung
liver
vascular
smooth
muscl
wherea
receptor
mainli
express
adren
pituitari
gland
burson
et
al
date
pharmacolog
antagonist
clearli
discrimin
receptor
studi
mice
use
target
gene
manipul
provid
insight
function
role
subtyp
vivo
delet
receptor
gene
significantli
decreas
rest
blood
pressur
heterozyg
homozyg
receptor
mice
ito
et
al
ang
ii
infus
result
diminish
pressor
respons
receptor
mutant
wherea
respons
virtual
abolish
mutant
addit
express
level
renin
mrna
plasma
renin
activ
markedli
increas
receptor
knockout
mice
sugaya
et
al
delet
receptor
gene
affect
rest
blood
pressur
alter
pressur
respons
ang
ii
chen
et
al
taken
togeth
find
indic
import
role
receptor
mediat
pressur
respons
mice
receptor
defici
associ
impair
develop
surviv
doubl
knockout
mice
lack
receptor
display
phenotyp
similar
observ
angiotensinogen
knockout
mice
tsuchida
et
al
observ
togeth
fact
ang
ii
caus
pressor
respons
knockout
mice
enalapril
pretreat
oliverio
et
al
suggest
compensatori
role
receptor
addit
vitro
studi
demonstr
receptor
import
regul
ang
ii
contractil
respons
mous
aorta
femor
arteri
zhou
et
al
receptor
belong
seventransmembran
gproteincoupl
receptor
superfamili
coupl
wide
varieti
second
messeng
system
includ
phospholipas
kinas
c
pathway
phospholipas
arachidon
acid
pathway
phospholipas
dphosphatidylcholinephosphatid
acid
pathway
tyrosin
kinas
map
kinas
cjun
ntermin
kinas
mehta
griendl
receptor
stimul
result
rapid
intern
ang
iiat
receptor
complex
follow
either
receptor
degrad
lysosom
receptor
recycl
cell
surfac
mehta
griendl
intern
ang
ii
propos
activ
cytoplasm
nuclear
receptor
prior
intracellular
degrad
thoma
et
al
furthermor
zou
cowork
recent
demonstr
mechan
stretch
result
receptor
activ
ligandindepend
manner
interestingli
consequ
activ
could
prevent
receptor
blocker
zou
et
al
sever
report
describ
crosstalk
receptor
receptor
eg
bradykinin
type
b
receptor
receptor
b
receptor
form
stabl
heterodim
enhanc
gprotein
activ
alter
receptor
sequestr
abdalla
et
al
adrenoceptor
crosstalk
enhanc
respons
adrenoceptor
agonist
purdi
weber
interestingli
although
postjunct
receptor
interact
adrenoceptor
subtyp
prejunct
receptor
facilit
noradrenalin
releas
sympathet
nerv
end
subtyp
guimara
pinheiro
contrast
wellcharacter
receptor
function
receptor
much
less
understood
gener
assum
receptor
counteract
respons
mediat
receptor
hein
et
al
ichiki
et
al
abdalla
et
al
schuijt
et
al
batenburg
et
al
receptor
involv
physiolog
process
like
develop
tissu
remodel
inhibit
cell
growth
stimul
apoptosi
regul
blood
pressur
vasodilat
natriuresi
neuron
activ
evid
receptor
mediat
vasodilat
larg
base
two
approach
indirect
approach
show
enhanc
respons
ang
ii
presenc
receptor
blockad
gene
disrupt
hein
et
al
ichiki
et
al
batenburg
et
al
van
esch
et
al
direct
approach
show
receptorinduc
respons
appli
either
partial
receptor
agonist
ang
ii
presenc
receptor
blocker
widdop
et
al
li
widdop
receptor
gene
first
clone
mukoyama
et
al
receptor
gene
share
sequenc
homolog
receptor
counterpart
encod
protein
amino
acid
molecular
mass
kda
locat
x
chromosom
human
rodent
fetal
tissu
receptor
predomin
subtyp
situat
chang
rapidli
birth
result
receptor
becom
domin
subtyp
adult
tissu
widdop
et
al
yet
adult
receptor
still
detect
varieti
tissu
includ
uteru
ovari
adren
medulla
heart
blood
vessel
brain
bottari
et
al
import
consid
distribut
receptor
depend
age
speci
also
subject
chang
express
pregnanc
patholog
condit
hypertens
heart
failur
vascular
injuri
see
bottari
et
al
de
gasparo
et
al
two
group
report
delet
receptor
mice
led
increas
pressor
respons
ang
ii
hein
et
al
ichiki
et
al
addit
ichiki
et
al
report
signific
increas
blood
pressur
hemizyg
receptor
mice
wherea
blood
pressur
significantli
increas
similar
model
describ
hein
cowork
mutant
lack
receptor
gene
show
lower
bodi
temperatur
impair
exploratori
behavior
remark
despit
wide
express
fetu
receptor
seem
requir
embryon
develop
morpholog
development
differ
found
homozyg
hemizyg
receptor
mice
wildtyp
control
possibl
receptor
knockout
mice
display
delay
express
calponin
hcaldesmon
birth
yamada
et
al
pregnanc
ang
ii
level
elev
fetu
also
expos
high
ang
ii
level
postul
receptor
play
role
regul
ang
ii
respons
order
prevent
fetal
hypertens
perlega
et
al
like
receptor
receptor
belong
g
proteincoupl
receptor
superfamili
howev
contrast
receptor
receptor
intern
upon
bind
ang
ii
widdop
et
al
two
major
pathway
describ
receptor
signal
nouet
nahmia
activ
protein
phosphatas
caus
protein
dephosphoryl
b
activ
nitric
oxid
guanosin
cyclic
cgmp
pathway
three
specif
phosphatas
link
receptor
activ
mapk
phosphatas
phosphatas
protein
phosphatas
growth
factor
includ
ang
ii
via
receptor
mediat
growth
promot
action
tyrosin
kinas
receptor
sever
kinasedriven
phosphoryl
step
activ
receptor
counteract
growthpromot
action
dephosphoryl
subsequ
activ
phosphatas
addit
inhibitori
effect
growth
dephosphoryl
eg
also
seem
play
import
role
stimul
apoptosi
horiuchi
et
al
sever
studi
shown
receptormedi
vasodil
endotheliumdepend
phenomenon
involv
b
receptor
cgmp
wiemer
et
al
siragi
carey
fig
initi
vitro
studi
use
endotheli
cell
show
stimulatori
effect
ang
ii
cgmp
product
figur
receptormedi
relax
involv
either
intracellular
activ
kininogenas
subsequ
bradykinin
type
b
receptor
activ
direct
activ
synthas
no
downstream
signal
product
product
abolish
block
b
receptor
nitric
oxid
synthas
no
wiemer
et
al
subsequ
vivo
studi
confirm
receptorinduc
rise
cgmp
involv
bradykinin
siragi
carey
vitro
studi
endotheli
cell
report
intracellular
acidosi
result
receptor
activ
stimul
bradykinin
format
activ
kininogenas
tsutsumi
et
al
katada
majima
abl
show
product
bradykinin
activ
rat
mesenter
arteri
suggest
b
receptor
mediat
vasodilat
endogen
bradykinin
releas
upon
receptor
activ
katada
majima
agreement
concept
delet
b
receptor
enhanc
ang
iiinduc
hypertens
respons
vivo
cervenka
et
al
addit
studi
conclud
product
follow
receptor
stimul
may
also
occur
independ
b
receptor
direct
no
activ
abadir
et
al
possibl
involv
calcineurinnuclear
factor
activ
cell
pathway
ritter
et
al
b
receptor
coexpress
variou
tissu
hypothesi
rais
receptor
form
heterodim
interact
receptor
crosstalk
recent
studi
rat
pheochromocytoma
cell
appli
fluoresc
reson
energi
transfer
confirm
hypothesi
abadir
et
al
heterodim
format
appear
depend
receptor
number
express
also
requir
receptor
stimul
consequ
heterodim
format
possibl
receptor
activ
result
b
receptor
activ
without
intermedi
bradykinin
synthesi
batenburg
et
al
addit
interact
b
receptor
receptor
also
known
interact
counterpart
transfect
studi
fetal
fibroblast
show
receptor
form
heterodim
receptor
function
specif
receptor
antagonist
abdalla
et
al
possibl
receptorinduc
vasodilat
depend
simultan
receptor
activ
receptormedi
respons
note
absenc
receptor
van
esch
et
al
furthermor
import
consid
data
obtain
absenc
receptor
complex
receptor
downregul
receptor
ligandindepend
manner
jin
et
al
receptor
knockout
mice
display
increas
receptor
express
addit
interact
receptor
receptor
also
downregul
renin
biosynthesi
therebi
inhibit
format
ang
ii
siragi
et
al
ang
ii
metabol
whole
rang
peptidas
angiotensinas
although
initi
thought
metabolit
ang
ii
inact
clear
least
sever
metabolit
function
sometim
mediat
via
nonat
receptor
import
peptid
ang
ang
ang
iii
ang
ang
iv
fig
ang
form
ang
action
neutral
endopeptidas
prolyl
endopeptidas
also
ang
degrad
product
ang
ang
ii
vicker
et
al
ang
gener
believ
counteract
respons
ang
ii
although
report
similar
distinct
action
ang
ii
santo
et
al
ang
induc
relax
sever
vascular
bed
fact
relax
could
block
select
ang
antagonist
dala
ang
suggest
involv
specif
ang
receptor
santo
et
al
inde
ma
protooncogen
g
proteincoupl
receptor
propos
receptor
ang
santo
et
al
ang
potenti
bradykinininduc
respons
tom
et
al
releas
brosnihan
et
al
via
ma
receptor
stimul
ma
receptor
mrna
express
detect
heart
testi
kidney
brain
metzger
et
al
mice
defici
masreceptor
lack
antidiuret
action
ang
acut
water
load
aorta
longer
relax
respons
ang
santo
et
al
ma
mice
also
character
impair
heart
function
indic
import
role
ma
receptor
mainten
structur
function
heart
santo
et
al
although
masreceptor
held
respons
respons
ang
sever
pharmacolog
mechan
receptor
affect
ang
slow
substrat
ace
ang
may
also
function
ace
inhibitor
result
decreas
ang
ii
format
potenti
bradykinininduc
vasodilat
tom
et
al
furthermor
ang
act
receptor
antagonist
low
concentr
stegbauer
et
al
exert
receptor
agonist
effect
high
concentr
van
rodijnen
et
al
link
ang
receptor
recent
propos
infus
ang
receptor
blockad
unmask
vasodepressor
respons
consciou
shr
rat
could
attenu
blockad
receptor
b
receptor
no
possibl
masat
andor
masat
receptor
heterodim
exist
castro
et
al
lemo
et
al
action
aminopeptidas
ang
ii
convert
ang
iii
turn
convert
ang
iv
aminopeptidas
n
ardail
chansel
ang
iii
mediat
classic
respons
ang
ii
stimul
aldosteron
secret
vasoconstrict
like
involv
bind
receptor
affin
ang
iii
receptor
somewhat
lower
ang
ii
wright
hard
respons
ang
iii
less
efficaci
ang
ii
possibl
due
acceler
metabol
circul
latter
relat
wide
distribut
aminopeptidas
n
initi
hydrolysi
ang
iii
ang
ii
thought
ang
iii
might
final
mediat
action
ang
ii
exampl
central
action
ang
ii
vasopressin
secret
rat
depend
ang
iii
effect
absent
specif
blockad
aminopeptidas
zini
et
al
addit
ang
iii
ang
ii
mediat
excret
na
excret
receptor
presenc
receptor
blockad
padia
et
al
ang
iv
initi
believ
biolog
activ
base
two
import
find
receptor
display
poor
affin
ang
iv
ang
iv
elicit
characterist
ang
ii
respons
like
ang
iii
discoveri
specif
ang
iv
bind
site
design
receptor
chang
view
swanson
et
al
purif
receptor
identifi
insulinregul
aminopeptidas
albiston
et
al
protein
abundantli
found
vesicl
contain
insulinsensit
glucos
transport
keller
et
al
receptor
express
occur
brain
spinal
cord
heart
kidney
colon
prostat
adren
gland
bladder
vascular
smooth
muscl
cell
wright
hard
de
gasparo
et
al
ang
iv
receptor
appear
involv
facilit
memori
learn
wright
et
al
ang
iv
infus
caus
vasorelax
cerebr
renal
vascular
bed
possibl
increas
no
activ
patel
et
al
hand
also
studi
show
ang
iv
weak
agonist
activ
toward
receptor
induc
vasoconstrict
van
rodijnen
et
al
close
associ
receptor
suggest
ang
iv
might
modul
glucos
uptak
soon
realiz
angiotensin
product
tissu
site
greater
import
angiotensin
gener
circul
mani
investig
start
unravel
local
angiotensin
product
might
occur
initi
thought
compon
requir
local
ang
ii
product
ie
renin
angiotensinogen
ace
would
produc
tissu
site
infus
radiolabel
angiotensin
allow
quantif
uptak
bloodderiv
angiotensin
tissu
confirm
major
tissu
ang
ii
produc
tissu
site
deriv
blood
schuijt
danser
ace
wellknown
abundantli
express
virtual
everi
tissu
bodi
main
site
surfac
endotheli
cell
thu
local
synthesi
beyond
doubt
although
angiotensinogen
mrna
detect
outsid
liver
direct
proof
actual
angiotensinogen
synthesi
import
site
local
angiotensin
product
eg
heart
vessel
wall
lack
instanc
isol
perfus
heart
releas
angiotensinogen
therefor
major
tissu
angiotensinogen
probabl
hepat
origin
fact
angiotensinogen
neither
intern
bind
membran
combin
observ
angiotensinogensynthes
cell
releas
angiotensinogen
extracellular
space
klett
et
al
rather
store
intracellularli
indic
angiotensin
gener
must
occur
extracellularli
thu
tissu
angiotensin
gener
restrict
interstiti
space
andor
cell
surfac
fig
follow
bilater
nephrectomi
tissu
renin
angiotensin
level
drop
level
detect
limit
campbel
et
al
danser
et
al
katz
et
al
suggest
major
tissu
renin
local
produc
kidneyderiv
without
renin
angiotensin
product
presenc
renin
cardiac
membran
fraction
danser
et
al
suggest
circul
renin
addit
diffus
interstiti
space
katz
et
al
van
den
eijnden
et
al
may
bind
reninbind
protein
receptor
tissu
site
recent
discoveri
sever
receptor
discuss
support
concept
interest
addit
observ
receptor
also
bind
prorenin
prorenin
upon
bind
becom
catalyt
activ
view
much
higher
prorenin
renin
level
attract
concept
prorenin
rather
renin
contribut
tissu
angiotensin
gener
studi
pro
renin
receptor
blocker
diabet
rat
confirm
concept
ichihara
et
al
unexpectedli
howev
blocker
affect
tissu
angiotensin
level
control
rat
although
prorenin
level
latter
rat
lower
diabet
rat
moreov
despit
fact
prorenin
still
present
circul
blood
nephrectomi
danser
et
al
tissu
angiotensin
level
close
zero
suggest
prorenin
contribut
tissu
angiotensin
product
involv
prorenin
renal
rather
extraren
origin
current
known
differ
renal
extraren
prorenin
relat
degre
glycosyl
vitro
studi
use
isol
perfus
rat
langendorff
heart
fulli
confirm
idea
renin
angiotensinogen
uptak
underli
tissu
angiotensin
product
buffer
perfus
releas
ra
compon
could
demonstr
coronari
effluent
interstiti
fluid
ad
renin
perfus
fluid
renin
start
accumul
interstiti
fluid
reach
steadyst
level
compart
ident
level
coronari
circul
find
angiotensinogen
similar
stop
exposur
renin
reveal
biphas
washout
curv
agreement
concept
renin
present
extracellular
fluid
also
bind
receptor
angiotensinogen
washout
monophas
angiotensin
synthesi
occur
simultan
perfus
renin
angiotensinogen
interestingli
heart
transgen
rat
overexpress
angiotensinogen
angiotensin
releas
continu
stop
renin
perfus
ie
renin
longer
present
coronari
circul
et
al
due
fact
receptorbound
renin
continu
gener
ang
steadi
state
cardiac
tissu
level
ang
high
expect
assum
ang
restrict
extracellular
fluid
de
lannoy
et
al
schuijt
et
al
contrast
tissu
ang
ii
level
much
higher
pretreat
receptor
antagonist
greatli
reduc
cardiac
tissu
ang
ii
level
renin
angiotensinogen
perfus
suggest
local
gener
ang
ii
accumul
tissu
site
bind
receptor
subsequ
subcellular
fraction
studi
confirm
tissu
ang
ii
ang
locat
intracellularli
schuijt
et
al
van
kat
et
al
due
fact
receptorbound
ang
ii
rapidli
intern
intracellular
degrad
occur
base
observ
surpris
tissu
ang
ii
content
correl
directli
tissu
receptor
densiti
wide
rang
vitro
studi
provid
evid
exist
enzym
renin
ace
gener
ang
ii
includ
cathepsin
kallikrein
tonin
chymas
hackenth
et
al
urata
et
al
vivo
import
altern
pathway
question
fact
ang
ii
virtual
absent
plasma
tissu
nephrectom
anim
includ
human
argu
role
nonrenin
angiotensinogenconvert
enzym
vivo
similar
situat
exist
chymas
present
cardiac
interstitium
mast
cell
endotheli
cell
vitro
studi
provid
evid
import
role
chymas
convers
ang
ang
ii
urata
et
al
tom
et
al
vivo
evid
chymasedepend
ang
ii
gener
could
obtain
sari
et
al
moreov
angiotensinogen
ace
knockout
mice
similar
phenotyp
tanimoto
et
al
krege
et
al
ace
delet
reduc
ang
ii
level
tissu
circul
campbel
et
al
thu
least
mice
ace
main
ang
iigener
enzym
vivo
discuss
receptor
express
low
undetect
adult
tissu
contrast
high
express
fetal
tissu
howev
receptor
reappear
pathophysiolog
condit
instanc
kidney
receptor
express
increas
inflamm
apoptosi
proteinuria
occur
ruizortega
et
al
interestingli
transgen
receptoroverexpress
mice
display
less
glomerular
injuri
proteinuria
transform
growth
factor
express
subtot
nephrectomi
model
hashimoto
et
al
suggest
reappear
receptor
patholog
condit
part
protect
mechan
instanc
relat
enhanc
product
hiyoshi
et
al
howev
studi
confirm
counterregulatori
protect
action
receptor
kidney
duke
cowork
report
receptor
mediat
vasoconstrict
renal
medulla
rat
oppos
vasodil
effect
mediat
receptor
model
duke
et
al
heart
wide
rang
anim
studi
reveal
increas
receptor
express
patholog
condit
eg
pressur
overload
hypertens
ischemia
postmyocardi
infarct
wiemer
et
al
wu
et
al
schuijt
et
al
yayama
et
al
studi
fail
human
heart
confirm
anim
data
simultan
show
downregul
receptor
asano
et
al
wharton
et
al
studi
receptor
antagonist
wide
accept
receptor
play
major
role
postmyocardi
remodel
process
mediat
fibrosi
hypertrophi
schieffer
et
al
sinc
benefici
effect
receptor
blockad
follow
myocardi
infarct
diminish
receptor
mice
reason
assum
increas
ang
ii
level
occur
receptor
blockad
see
exert
benefici
effect
via
receptor
stimul
inde
transgen
mice
overexpress
receptor
heart
display
improv
cardiac
hemodynam
postmyocardi
infarct
nodepend
manner
bove
et
al
furthermor
treatment
either
receptor
antagonist
b
receptor
antagonist
reduc
benefici
effect
receptor
blockad
wildtyp
mice
follow
myocardi
infarct
therefor
benefici
effect
receptor
heart
involv
b
receptornocgmp
pathway
contrast
observ
studi
shown
receptor
like
receptor
induc
cardiac
hypertrophi
fibrosi
senbonmatsu
et
al
ichihara
et
al
explain
discrep
data
hypothes
receptor
upregul
benefici
earli
patholog
phase
counteract
hypertrophi
fibrosi
chronic
stimul
receptor
instanc
high
ang
ii
level
occur
receptor
blockad
deleteri
effect
cardiac
recoveri
schneider
lorel
knowledg
effect
receptor
human
heart
come
polymorph
studi
although
data
often
contradictori
receptor
gene
variant
link
cardiac
hypertrophi
coronari
ischemia
schmieder
et
al
herrmann
et
al
alfakih
et
al
without
know
howev
whether
base
inceas
decreas
receptor
densiti
receptormedi
vasodil
isol
human
coronari
microarteri
increas
age
batenburg
et
al
sinc
endotheli
function
decreas
age
could
point
increas
receptor
express
face
decreas
endotheli
function
agreement
concept
receptor
densiti
increas
patholog
condit
receptor
express
also
increas
peripher
resist
arteri
hypertens
diabet
patient
treatment
receptor
blocker
result
enhanc
ang
iiinduc
vasodil
savoia
et
al
recent
studi
shown
receptor
also
express
variou
carcinoma
deshay
nahmia
assum
receptor
contribut
tumor
growth
vascular
fujita
et
al
one
may
predict
receptor
counteract
effect
receptor
stimul
thu
inhibit
growth
vascular
silvestr
et
al
howev
proangiogen
effect
receptor
also
describ
occur
conjunct
receptor
activ
block
ra
possibl
three
level
renin
ace
receptor
betaadrenoceptor
blocker
antagon
reninreleas
adrenoceptor
juxtaglomerular
cell
first
drug
suppress
ra
drug
lower
renin
campbel
et
al
ang
ang
ii
therebi
reduc
degre
receptor
stimul
tabl
subsequ
ace
inhibitor
introduc
drug
lower
ang
ii
given
wide
varieti
avail
angiotensinas
lead
substanti
ang
accumul
rather
result
metabol
ang
differ
compensatori
pathway
eg
neutral
endopeptidas
consequ
ang
level
rise
ace
inhibit
therebi
allow
ang
contribut
benefici
effect
ace
inhibitor
tom
et
al
simultan
due
interfer
ang
ii
gener
neg
feedback
loop
system
regul
renin
releas
affect
thu
kidney
releas
renin
therefor
depend
degre
ace
inhibit
ang
ii
level
may
rise
sometim
level
baselin
campbel
et
al
van
kat
et
al
instanc
ace
inhibit
rise
renin
suffici
fulli
restor
ang
ii
level
wherea
rise
renin
would
increas
ang
ii
twofold
baselin
level
addit
prolong
ace
inhibit
known
upregul
ace
given
compensatori
mechan
surpris
proven
difficult
show
blood
plasma
tissu
ang
ii
level
remain
suppress
continu
ace
inhibit
van
kat
et
al
inde
pig
treat
captopril
week
postmyocardi
infarct
cardiac
ang
ii
level
increas
compar
untreat
control
pig
fig
although
ang
ii
may
theoret
stimul
receptor
must
kept
mind
receptor
stimul
may
occur
less
effici
normal
without
ace
inhibitor
treatment
ace
gener
ang
ii
highli
effici
manner
close
proxim
receptor
chronic
ace
inhibit
increas
ang
gener
still
allow
ang
ii
gener
either
noninhibit
ace
nonac
convert
enzym
like
chymas
van
kat
et
al
howev
type
ang
ii
gener
less
effici
result
high
level
region
receptor
stimul
particular
ang
ii
gener
chymas
local
adventitia
subject
rapid
metabol
interstiti
space
way
receptor
schuijt
et
al
de
lannoy
et
al
thu
less
like
result
high
region
receptor
occup
therefor
low
overal
receptor
occup
occur
minimum
per
cell
requir
induc
effect
receptor
blocker
avail
sinc
earli
also
caus
rise
renin
ang
ii
blood
tissu
well
metabolit
increas
parallel
renin
although
result
receptor
stimul
nonat
receptor
includ
receptor
ma
may
stimul
excess
discuss
feasibl
least
part
benefici
effect
receptor
blocker
due
receptor
stimul
widdop
et
al
final
renin
inhibitor
soon
clinic
avail
drug
lower
ang
ii
evid
least
blood
plasma
alreadi
avail
nussberg
et
al
azizi
et
al
whether
renin
inhibitor
also
decreas
tissu
ang
ii
level
yet
known
relat
fact
figur
plasma
cardiac
tissu
angiotensin
level
pig
either
untreat
treat
ace
inhibitor
captopril
receptor
antagonist
eprosartan
week
myocardi
infarct
p
vs
untreat
data
deriv
van
kat
et
al
renin
inhibitor
primarili
block
human
renin
much
lesser
degre
rat
mous
porcin
renin
thu
renin
inhibitor
test
easili
wellestablish
anim
model
theoret
decreas
ang
ii
level
renin
inhibit
prevent
receptor
stimul
well
stimul
receptor
angiotensin
metabolit
although
renin
rise
renin
inhibitor
treatment
like
ra
blocker
treatment
renin
enzymat
activ
due
presenc
renin
inhibitor
thu
renin
inhibitor
may
offer
complet
suppress
ra
although
also
impli
put
benefici
effect
mediat
ma
receptor
longer
occur
far
appear
diminish
effect
renin
inhibitor
least
blood
pressur
gradman
et
al
ang
ii
gener
tissu
site
stimul
receptor
local
gener
depend
larg
angiotensinogen
renin
andor
prorenin
taken
blood
latter
uptak
possibl
involv
recent
discov
pro
renin
receptor
ace
gener
local
appear
main
ang
iigener
enzym
ang
ii
whole
rang
metabolit
import
ang
ang
iii
ang
iv
enzym
gener
metabolit
includ
recent
character
well
put
nonat
receptor
like
ma
receptor
stimul
receptor
like
contribut
benefici
effect
ra
blocker
particular
receptor
antagon
receptor
upregul
pathophysiolog
condit
gener
believ
counteract
effect
receptor
stimul
howev
studi
agre
aspect
thu
remain
seen
effect
drug
complet
suppress
ra
ie
renin
inhibitor
compar
allowrequir
receptor
stimul
like
ace
inhibitor
receptor
antagonist
